News
We’re keeping the Thoroughbred industry informed with the latest announcements from and activities of the Horseracing Integrity & Welfare Unit.
All
- Appointments
HISA and HIWU Name Alan Foreman as Ombudsman
- Outreach
Guidance of the Horseracing Integrity and Safety Authority: Multiple Controlled Medication Rule Violations Prior to Notice
- Outreach
Horsemen Advisory Regarding “HISA/HIWU-approved” Labels on Supplements
- Outreach
Guidance of the Horseracing Integrity and Safety Authority: Electrolytes
- Outreach
Guidance of the Horseracing Integrity and Safety Authority: Provisional Suspensions
.png&w=750&q=75)
- Outreach
HIWU Launches Mobile App; Substance Lookup Tool and Educational Resources Among Key Features
- Outreach
Advisory: Permitted Medications for Routine Timed Workouts
- Outreach
Clarification for Anti-Ulcer Medication, Isotonic Electrolyte Solution Administration and Products Intended for External Use Only
- General
HISA / HIWU Media Briefing – June 8, 2023
- General
HISA ADMC Program in Full Swing Under HIWU; Belmont Stakes to be First Triple Crown Race Run Under Program
- General
HIWU Relaunches Anonymous Whistleblower Platforms in Partnership with RealResponse; Platforms Now Accepting Tips for both ADMC and Racetrack Safety Programs
- Outreach
HISA Anti-Doping and Medication Control Program to Relaunch May 22, 2023, Under Enforcement of HIWU
- General
Statement from the Horseracing Integrity & Welfare Unit
- Outreach
HIWU Notice on Dietary Supplements and Institution of 30-Day Grace Period
- General
Update on Graded and Listed Stakes Race Compliance with TOBA Drug Testing Requirements under the HISA ADMC Program
- General
Horseracing Integrity & Welfare Unit Launches Anonymous Whistleblower Platforms; Whistleblower Service is Operating in Partnership with RealResponse
- General
HISA and HIWU Highlight “Day One” Changes on Eve of Expected Implementation of Anti-Doping and Medication Control Program
- General
HIWU Set to Administer HISA Anti-Doping and Medication Control Program in Cooperation with State Racing Commissions, Racetracks, and Laboratories
- Appointments
Internal Adjudication Panel Members Announced; Group to Hear HISA ADMC Program Controlled Medication Rule Violation Cases
- Outreach
Notice on the use of Bisphosphonates Under the HISA Anti-Doping and Medication Control Program
- Outreach